Murakkab drugs of Unani medicine have remained an important aspect of disease treatment since antiquity. Physicians prepared different formulations for various diseases. The formulations thus prepared have always been of two categories. One category of Murakkab drugs was those which were formulated empirically and remained in use without conceptual framework behind these formulations. These formulations were categorized as Mujarrab (tested) formulations. The other category of formulations was prepared in consideration with theoretical framework of Mizaj (temperament) and Usoole ilaj (treatment strategy) and then tested by physicians. This category forms a large chunk of formulations in the formulary sections of the literature of Unani medicine. Present paper explores various approaches for formulating Murakkab drugs of the second category keeping in view the actions of the ingredients of the drug formulation, and treatment strategy of the disease for which the formulation was prepared. It elucidates the approaches of formulating compound drug formulations with the logic of including various individual ingredients. The study exemplifies two compound formulations to illustrate the approaches used to formulate compound formulations of Unani medicine.
Introduction
Unani medicine is an ancient system of medicine originated from Greece and was developed during the Arab civilization. It was the Greek philosopher and physician-Hippocrates, on whose teachings the theoretical framework of medicine is based. After him a number of other Greek scholars enriched the system considerably. Of them Galen stands out as the one who stabilized its foundation, on which Arab physicians like Razi and Avicenna constructed the imposing edifice [1] . According to basic concepts of Unani medicine there is a power of self preservation and/or adjustment in an individual which is called defense constitution which gets affected in diseased conditions and needs restoration to normal by the use of various therapies prescribed in the system [2] . Unani medicine strives to find out the best possible ways by which a person can lead to a healthy life.
There are four types of therapies, described in Unani literature, for maintaining health and treating disease. These are Ilaj bittadbeer (Regimental therapy), Ilaj bil-ghiza, (Dietotherapy), Ilaj biddawa (Pharmacotherapy) and Ilaj bil-jarahat (Surgery) [3] . Ilaj bittadbeer mainly consists of non-pharmacological procedures like Riyazat (exercise), Dalak (massage), Hammam (Turkish bath), Taaleeq (leeching), Hijamah (cupping), etc. Ilaj bil-ghiza is based on recommendation/restriction of various diets that suit a disease condition. Pharmacotherapy involves administration of drugs to correct the disease [4] .
The drugs employed are mainly derived from plants; some are from animals and a few of mineral origin [5] . Both single crude drugs and compound preparations are used for the treatment purpose. Single drugs or their combinations in raw form are preferred over compound formations [6] . Most of the naturally occurring drugs used in this system are safe for human use, while drugs that are toxic in crude form are first processed and purified in many ways before use so as to make them safer [7] . Other traditional medicines also emphasize on use of polyherbal formulations with specific guidelines. According to Chinese medicine, strategic combination of different ingredients of herbs is necessary to generate specific and synergistic effects. Single herbs prescriptions are called Danfang while multiple herb prescriptions are called Fufang. Fufang are much more commonly used than Danfang, which are thought to synergize the therapeutic effects of different ingredients and minimize their toxicities [8, 9] .
The treatment through Unani drugs has been rationalized in the manner that if single drug is not adequate enough to treat a disease then Murakkab drug may be prescribed [10, 11] . Use of Murakkab drug for treating a disease was started centuries back by Unani physicians. The principles underlying formulating a Murakkab have been enough detailed in the literature [12, 13] . Present study explores various approaches of formulating a Murakkab drug for a disease. The two approaches pharmacological and the clinical approaches illustrated are not mutually exclusive, but Unani scholars have invariably held one or the other approach as basis for formulating the Murakkab drug formulations.
Literature Review
The approaches of formulating a Unani Murakkab drug was sorted out by the extensive research review from Unani literatures. A thorough analysis of these approaches of formulating a Murakkab was undertaken and the rules were applied to two known Murakkab to explore the applicability of these approaches.
Observations
In this study Unani literatures were surveyed for various guidelines and approaches for formulating a Murakkab drug. It was observed that there are two approaches of formulating Murakkab drugs in Unani system of medicine. Murakkab drugs are formulated either taking into account drug actions that are in concordance to the nature of disease along with ameliorating the safety concern of the use of these drugs as proposed by Ibne Sina; or keeping the Usoole Ilaj (Treatment Strategy) in perspective and choosing the single drugs to suit it [13] . The former approach henceforth will be called pharmacological approach and the later the clinical approach of formulating a Murakkab.
Pharmacological approach of formulating Murakkab drug
Approach of formulating Murakkab drugs through drug actions follows the principle of Qiyas (Hypothesis) and was adopted and suggested by Ibne Sina, rests on the principle that base drug(s) are chosen in accordance to disease severity and derangement in mizaj (Impaired Temperament) with addition of Musleh (Corrective) and Badarqah (Vehicle). According to Ibne Sina there are 2 types of single drugs in a compound formulation. In first type, single drugs which are the base drugs of a compound are termed as chief ingredients, if these base drugs are excluded from the compound the whole formula of Murakkab drug will be disturbed while in second type, single drugs which are added in the formulations for reasons like correctives, vehicles, manipulating rate of absorption, retaining the drug for longer time at the site of action, directing the drug towards the lesion apart from synergism or partial antagonism of drug action by these drugs [14] ( Fig. 1) .
The Afa'al (Actions) of drugs has got the primary importance and management of the disease is looked at from the basic alteration drug ingredient (s) make via its Taseer (Effect) on the diseased body. The Taseer of the drug is viewed in terms of the Ta'deel in Mizaj (Temperamental Equilibrium) through Mizaje Uoola (Basic Temperament), and/or Sanvi (Secondary Temperament). Moreover, specificity of drug action via Zulkhassa (Drugs with unknown mechanism of action) is also taken care as drugs specific to affected organ are invariably included in the dosage formulation.
Clinical approach of formulating Murakkab drug
Approach through Usoole Ilaj of the disease emphasizes on selecting and combining single drugs on the basis of the treatment plan for the particular disease. This approach is described by Unani physicians in the chapter of Ilaj wa moalijah (Treatment) of every disease [15, 16] . They prescribed and emphasized to combine some single drugs according to Usoole Ilaj or need of the particular disease, for which the compound drug was initially devised. According to this approach, first it is noted that for which disease this Murakkab drug is prepared then we go through the Usoole Ilaj of the particular disease and finally required single drugs are combined according to the treatment plan ( Fig. 2) .
These types of Murakkab drugs are numerous and in Qarabadeen (Formularies) usually they are detailed without specific names, but the prescriptions have well documented histories as same formulas are found in various Qarabadeen and authors have taken care for the origin also. As an example, some habb and qurs (Pills and Tablets) ascribed to Galen, Avicenna, Shareef khan etc. and are not mentioned with a specific name for the Murakkab. 3. Analysis of exemplified Murakkab according to the approaches of formulating a compound drug
Qurse Ghareeqoon
This formulation has been described in the Unani literature in a precise way. The main indication is for Warme Salabate Tihal (Chronic Splenitis) [17] . (The ingredients are mentioned in Table 1 ).
Pharmacological approach of formulating a Murakkab
Ghareeqoon ( Tabasheer, Gule Surkh and sumbul-ut-teeb are also added in this formulation as Musleh (corrective) drugs. Tabasheer corrects the mazarrat (toxicity) produced by sumbul-ut-teeb while Gule Surkh protects testes against the mazarrat of Usarah Ghafis and Sumbul-utteeb corrects the adverse effects of Laakh on brain.
In this formulation drugs like Tabasheer and Gule Surkh are added for corrective reasons but these two drugs also produce mazarrat to baah (libido) and lungs. And there is no corrective drug for these two drugs in this formulation [18] .
Clinical approach of formulating a Murakkab
This formulation is used in Warme Salabate Tihal. According to Usoole ilaj of Warme Salabate Tihal following treatment plan is to be adopted in Unani medicine: [15] . Laakh is added in this formulation for its Munaqqie Akhlat (purifier for humors) property.
Majoon Najah
This formulation has been described in the Unani literature in a precise way. The main indication is for malikholiya (melancholia) [23e25]. (The ingredients are mentioned in Table 2 ).
Pharmacological approach of formulating a Murakkab
Bisfayij Fustuqi (Polypodium vulgare Linn.) is selected as a base drug for malikholiya in this formulation as it has Mushile Sauda 
Clinical approach of formulating a Murakkab
This formulation is used in Melancholia. According to Usoole ilaj of Melancholia following treatment plan is to be adopted in Unani medicine: Table 1 Analysis of ingredients of Qurse Ghareeqoon.
Ingredients
Mizaj Afa'al Mazarrat Musleh
Ghareeqoon
Hot [1] Dry [2,18e20] Mulattife Tabiyat, Muhallile Awram, Muhallile Riyah wa Nafakh, Mufattehe Sudade Jigar [18, 19, 21] For Kidney, produces karb and khunaq [22] Mastagi [18] Tabasheer Cold [2] Dry [2, 20, 23] Muqawwie meadah, Dafe'a Hararate jigar, Muhallil, Mufarreh, Muqawwie Qalb wa Jigar, Mujaffife Rutoobat, Dafe'a Qai Safrawi [19, 20] For Riyah and Baah [18, 19] Mastagi, Rubbussus [18] Gule Surkh Cold [1] Dry [1, 18] Muqawwie wa Mufarreh A'aza-e-raeesa, Muhallile Awram, Mufattehe Sudade Jigar [18, 19] For Baah, increases thirst [22] Aneesoon, Habbuzzalam [18, 22] UsarahGhafis Hot [1] Dry [2, 19, 21] Mulattife Mawad, Muqatte'a Akhlat, Muhallile Khanazeer, Mufattehe Urooq, Mufattehe Sudade Jigar [18, 19] For Testis [18, 19] Gule Surkh, Mastagi [18, 19] Sumbulutteeb Hot [1] Dry [2, 16, 20] Mufatteh, muhallil, Muqawwie Kabid, Mufattehe Sudad, Muqawwie Dimagh, Mujaffife Rutoobat [16, 20] For Kidney [16, 17] Tabasheer, Kateera [16, 17] Laakh Hot [2] Dry [2, 18, 22] Muqawwie Kabid wa Ahsha, Dafe'a Khafqan, Muhallil, Mufattehe Sudad, Munaqqie Akhlat [18, 19] For Head and Spleen [18, 19] Mastagi [22] Rewand Chini Hot [2] Dry [2] , M/quwa [18, 22] Mushil, Qabiz, Muqawwie Ahsha, Muqawwie Meadah, Ama'a wa jigar, Mudirre Haiz, Muhallil [18e20]
For week people [18] Samaghe babool, Kateera, bahdana [19, 22] Beekhe Kibar Hot [2] Dry [2, 22] Muhallil, Muqatte'a, Munaqqi, Mufatteh Sudad, Mudirre Haiz, Munaffise Balgham, Muqawwie meadah [19, 20, 22] For Gurdah and Masanah [22] Sikanjabeen, aneesoon, Shahad [19, 22] For spleen, produces qoolanj [18] Shahad and roghan badam [18] Tafreeh and Taqwiyat (mood elevation and potentiating) þ Taqwiyate A'asab wa Dimagh (potentiating nerves and brain) þ Taqwiyate Meadah (potentiating stomach) þ Taskeene Hararat (normalization of abnormal hotness) [15, 16] .
Majoon Najah as a drug formulation for Melancholia may thus be analyzed: 
Discussion
It was observed that there are two approaches of formulating Murakkab drugs. Murakkab drugs are formulated either through drug actions that were in concordance to the nature of disease along with ameliorating the safety concern of the use of these drugs as proposed by Ibne Sina; or keeping the Usoole Ilaj in perspective and choosing the single drugs to suit it [14] . Ibne Sina's approach rests on the principle that base drug(s) are chosen in accordance to disease severity and derangement in mizaj with addition of Musleh and Badarqah while Usoole Ilaj approach emphasizes on selecting drugs on the basis of the treatment plan for the particular disease. Among the two approaches, Ibne Sina emphasizes the characteristics of drugs as of primary importance and this approach seems to be better from the perspective of Ilmul Advia (pharmacology). Analysis of the exemplified drug formulation showed that the formulations were designed from Usoole Ilaj (clinical perspective) with good correlation with the approach of Ibne Sina.
With the analysis of two known compound drugs by the application of these two approaches underlying compound formulation it was found that the selected formulations were in consonance to both the approaches of formulating Murakkab drug. The approaches enumerated above may serve as base for rejecting spurious drug formulations with huge number of ingredients or irrationally conceived formulation.
All the approaches underlying Tarkeebe Advia (formulation of Murakkab drug) have been enumerated using Unani literature. These approaches are well documented, but have not been presently utilized for developing new Murakkab drugs. The reason for this lagging is not so unclear. The regulatory bodies need evidences in terms of efficacy and toxicity for licensing a product for human use. Though proprietary formulations have been allowed in some countries with evidence for the ingredients used in preparing a formulation, but most of them do not apply the conceptual basis of formulating a Murakkab drugs as stated in Unani medicine. This makes the enterprise seemingly a different category other than Unani medicine. The presented Unani rationale will enable a construct validation for huge number of formulation base and efforts for standardization will be consequently minimized. It is not far fetching for seeking similar rationale in other traditional systems of medicine. The integrated approach towards the traditional systems for cure of the disease and sustenance of health lies in the common grounds that these systems hold and understanding fundamental frameworks like rationale behind compound formulations will provide one of the solid basis for integration.
The stated framework in the present study needs further validation and caution is needed to use Murakkab prepared through qiyas as stated by Ibne Sina; 'it should be known that the tested drugs are better than the untested ones. The use of a smaller quantity of a drug is more beneficial than that of a larger quantity, particularly for a specific purpose. Tested drugs are better. The reason is that all compound medicines can be judged in two ways; (a) by its ingredients, and (b) by its composition. Untested medicines can be useful in respect of its ingredients only, but we cannot ascertain their acquired mizaj (temperament) before experiment. It may be either higher or lower or contrary to the required temperament. Tested medicines have already been ascertained in both aspects. Sometimes the constitutional form of a compound medicine is more important than the anticipated efficacy of its ingredients' [14] . The basic criterion of validating efficacy of the formulation remains to be the Tajurba (Clinical trial) in human, but these rules and approaches may serve new means to look at the huge resource base of drug formulations in a rational way. This might serve a way in reducing the number of ingredients in a classical formulation with similar efficacy profile (see Table 3 ).
Conclusion
The Murakkab drugs formulated by Unani physicians had a lot of consideration for the principles of treatment of a disease and precise knowledge of the various aspects of single drugs. The two approaches enumerated might furnish a logical base to approach the huge prescription and formulation base in the form of Qarabadeen (formularies) for their analysis and designing.
